To validate whether enhanced IL-6R expression on CD4+ T cells is causative of elevated Th17 response in patients with chronic hepatitis B, we studied the effect of blockade of IL-6R signaling on PMA/ionomycin and HBcAg induced IL-17 production by purified CD4T cells in vitro. This evidence concerns the gene IL17A and chronic hepatitis B virus infection.